Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 73.22
+1.69 (2.36%)
At close: Jul 31, 2026
Shanghai Medicilon Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 154.17 | 286.78 | 260.53 | 471.87 | 197.13 | 412.37 |
Short-Term Investments | 129.21 | 166.85 | 178.76 | - | - | - |
Trading Asset Securities | 281.42 | 113.41 | 261.22 | 518.23 | - | 100 |
Cash & Short-Term Investments | 564.81 | 567.03 | 700.52 | 990.1 | 197.13 | 512.37 |
Cash Growth | -20.44% | -19.05% | -29.25% | 402.25% | -61.52% | 9.96% |
Accounts Receivable | 521.04 | 454.85 | 598.26 | 671.88 | 575.77 | 250.3 |
Other Receivables | 12.55 | 11.34 | 18.04 | 3.05 | 3.06 | 1.61 |
Receivables | 533.59 | 466.19 | 616.31 | 674.93 | 578.83 | 251.91 |
Inventory | 146.65 | 112.22 | 104.36 | 165.52 | 171.12 | 83.48 |
Other Current Assets | 106.45 | 72.4 | 14.51 | 45.64 | 125.54 | 44.28 |
Total Current Assets | 1,352 | 1,218 | 1,436 | 1,876 | 1,073 | 892.04 |
Property, Plant & Equipment | 792.85 | 794.8 | 810.18 | 849.97 | 763.66 | 554.59 |
Long-Term Investments | 199.16 | 182.51 | 151.14 | 100.39 | 10.14 | - |
Other Intangible Assets | 266.88 | 269.2 | 278.15 | 286.9 | 294.05 | 231.61 |
Long-Term Deferred Tax Assets | 66.78 | 66.98 | 49.95 | 4.77 | 16.96 | 10.8 |
Long-Term Deferred Charges | 81.86 | 88.3 | 97.49 | 144.07 | 148.45 | 65.44 |
Other Long-Term Assets | 7.15 | 2.43 | 0.65 | 3.55 | 23.69 | 39.09 |
Total Assets | 2,766 | 2,622 | 2,823 | 3,266 | 2,330 | 1,794 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 230.68 | 175.8 | 144.5 | 190.24 | 218.3 | 120.1 |
Accrued Expenses | 75.18 | 96.09 | 57.27 | 53.09 | 50.02 | 53.09 |
Short-Term Debt | 218.78 | 179.68 | 292.24 | 349.39 | 229.41 | - |
Current Portion of Long-Term Debt | 14.53 | - | 0.02 | - | - | - |
Current Portion of Leases | - | 13.2 | 12.15 | 19.21 | 19.78 | 13.3 |
Current Income Taxes Payable | 6.47 | - | - | - | - | 10.15 |
Current Unearned Revenue | 114.21 | 79.09 | 64.99 | 62.6 | 85.51 | 152.3 |
Other Current Liabilities | 40.12 | 33.62 | 4.97 | 11.83 | 14.02 | 34.72 |
Total Current Liabilities | 699.96 | 577.48 | 576.15 | 686.36 | 617.04 | 383.66 |
Long-Term Debt | - | - | 21 | - | - | - |
Long-Term Leases | 54.15 | 54.56 | 20.67 | 14.28 | 25.71 | 30.26 |
Long-Term Unearned Revenue | 46.65 | 48.73 | 57.44 | 49.34 | 40.18 | 29.98 |
Long-Term Deferred Tax Liabilities | - | - | 0.14 | 5.09 | 43.87 | 22.16 |
Other Long-Term Liabilities | 7.09 | 7.09 | 7.71 | - | - | - |
Total Liabilities | 807.85 | 687.85 | 683.1 | 755.07 | 726.8 | 466.06 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 134.35 | 134.35 | 134.67 | 134.67 | 87.02 | 62.08 |
Additional Paid-In Capital | 1,637 | 1,629 | 1,662 | 1,662 | 714.74 | 717.57 |
Retained Earnings | 250.84 | 235.22 | 403.05 | 733.9 | 801.04 | 547.86 |
Treasury Stock | -64.01 | -64.01 | -59.99 | -19.99 | - | - |
Comprehensive Income & Other | -0.2 | -0.15 | 0.31 | 0.09 | -0.01 | - |
Total Common Equity | 1,958 | 1,934 | 2,140 | 2,511 | 1,603 | 1,328 |
Shareholders' Equity | 1,958 | 1,934 | 2,140 | 2,511 | 1,603 | 1,328 |
Total Liabilities & Equity | 2,766 | 2,622 | 2,823 | 3,266 | 2,330 | 1,794 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 287.46 | 247.44 | 346.08 | 382.88 | 274.9 | 43.56 |
Net Cash (Debt) | 277.35 | 319.59 | 354.44 | 607.22 | -77.76 | 468.8 |
Net Cash Growth | -13.02% | -9.83% | -41.63% | - | - | 0.61% |
Net Cash Per Share | 2.11 | 2.42 | 2.65 | 4.75 | -0.64 | 3.86 |
Filing Date Shares Outstanding | 130.13 | 123.8 | 133.67 | 134.67 | 121.82 | 121.68 |
Total Common Shares Outstanding | 130.13 | 123.8 | 133.67 | 134.67 | 121.82 | 121.68 |
Working Capital | 651.54 | 640.37 | 859.55 | 1,190 | 455.59 | 508.37 |
Book Value Per Share | 15.05 | 15.62 | 16.01 | 18.64 | 13.16 | 10.91 |
Tangible Book Value | 1,691 | 1,665 | 1,862 | 2,224 | 1,309 | 1,096 |
Tangible Book Value Per Share | 13.00 | 13.45 | 13.93 | 16.51 | 10.74 | 9.01 |
Buildings | - | 258.58 | 178.31 | 178.31 | 178.31 | 179.66 |
Machinery | - | 836.21 | 810.44 | 797.29 | 626.44 | 410 |
Construction In Progress | - | 87.23 | 169.19 | 142.71 | 140.39 | 100.62 |